Purchase Order 36C25619P0826
Award Date
4/15/19
Potential Completion Date
9/19/19
Potential Value
$151K
Federal Agency
Veterans Integrated Service Network 16
Awardee
Anovorx Distribution LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with performance at a facility in Bartlett, Tennessee. No set-aside designation was used for this order to supply the anti-neuromuscular drug Firdapse to support VHA healthcare programs in the...
The Department of Veterans Affairs Veterans Health Administration awarded a $16,928.97 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. Catalyst Pharmaceuticals, Inc. will provide the pharmaceutical products under its Pharmaceuticals and Drugs GSA Schedule contract with the General Services Administration. Performance will take place in Bartlett, Tennessee from December 6-8, 2023. The funding agency, VA-VHA Network 5, will utilize the products to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $34,394.25 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule master contract vehicle. Performance will take place in Bartlett, Tennessee through March 2023. No set-aside designation was applied to this order for FIRDAPSE, a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $154,859.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Catalyst Pharmaceuticals, Inc. for the provision of 10mg Firdapse (amifampridine) tablets. The order is for a firm fixed price and has a period of performance through October 31, 2022. The Pharmaceuticals and Drugs schedule, managed by GSA, provides government agencies access to...
This federal contract award is a firm fixed-price delivery order issued by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract, valued at $485,835.00, is for the supply of DALFAMPRIDINE 100 MG, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract was awarded on January 17, 2017, with a final completion date of...
This federal contract award was issued by the Veterans Integrated Service Network 20 (VISN 20), a component of the U.S. Department of Veterans Affairs (VA), to Catalyst Pharmaceuticals, Inc. The $132,865.82 firm fixed-price delivery order was placed against Catalyst's Federal Supply Schedule (FSS-61-IB) contract for the pharmaceutical product Amifampridine (Firdapse) 10mg Tablets, which is an FDA-approved treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a rare autoimmune disorder. The...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological disorder treatments. The contract is a Delivery Order against Acorda's existing Federal Supply Schedule (FSS) contract with the VA, valued at over $16.3 million and expiring in September 2024. This specific award, valued at $861,948.00, is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease symptoms....
The Department of Veterans Affairs Veterans Health Administration awarded a $203,147 delivery order to Catalyst Pharmaceuticals, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. Catalyst Pharmaceuticals will supply AMIFAMPRIDINE FIRDAPSE 10MG tablets to various VA facilities in Veterans Integrated Service Network 20. Performance will take place in Bartlett, Tennessee over a one year base period from November 1, 2023 through October 31, 2024. Pricing is firm fixed. This...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The $478,860.00 contract is for the delivery of pharmaceutical products, specifically Levodopa 42mg inhalation capsules used to treat Parkinson's disease symptoms. The contract is associated with Acorda's Federal Supply Schedule (FSS) contract with the VA, valued...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against Catalyst Pharmaceuticals' GSA Schedule contract for Pharmaceuticals and Drugs, with performance taking place in Bartlett, Tennessee. No set-aside designation was applied to this order to fulfill VHA medication needs as...